Business ❯ Pharmaceutical Industry ❯ Drug Development

Clinical Research

Market Competition Partnerships Market Approval Sanofi Novo Nordisk Market Impact Market Analysis Regulatory Affairs Eli Lilly and Company Lykos Therapeutics Market Withdrawal Global Trials Workforce Management MindMed UCB SA Wave Life Sciences Eli Lilly and Co Bayer Phase III Trials Drug Safety Moderna Veterinary Drugs Market Competitiveness Investment Risks Phase 3 Trials Stock Performance Market Applications AstraZeneca Market Reactions

Regeneron Slides as Melanoma Combo Fails to Beat Keytruda in Phase 3

The miss triggered target cuts alongside a securities investigation into prior comments.

Wave Life Sciences Shares Plunge 30% After Early Obesity Trial Readout

Asundexian Cuts Recurrent Stroke 26% Without More Major Bleeding in Phase III

Roche’s CT-388 Shows Up to 22.5% Placebo-Adjusted Weight Loss in Phase 2 as Phase 3 Nears

Sanofi Pushes Amlitelimab Toward 2026 Filings After Mixed Phase 3 Readouts

Takeda’s AI-Assisted Psoriasis Pill Succeeds in Phase 3, Outperforms Otezla

Junshi’s Subcutaneous Toripalimab Matches IV in Phase 3 NSCLC Trial as Company Prepares NDA

Inhibrx Drug Extends PFS in Chondrosarcoma Phase 2 as Shares Jump Over 70%

Sanofi’s Efdoralprin Alfa Shows Superior Biomarker Response to Plasma Therapy in Phase 2 AATD Trial

Alector Ends Latozinemab After Phase 3 Failure, Slashes Workforce

Bristol Myers’ Iberdomide Combo Hits MRD Goal in Phase 3 Myeloma Study

AstraZeneca’s Fasenra Misses Primary Endpoint in COPD Phase III Trial